BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bradley E, Hendrickson B, Daniels C. Fontan Liver Disease: Review of an Emerging Epidemic and Management Options. Curr Treat Options Cardiovasc Med 2015;17:51. [PMID: 26407544 DOI: 10.1007/s11936-015-0412-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Diamond T, Ovchinsky N. Fontan-associated liver disease: Monitoring progression of liver fibrosis. Clin Liver Dis (Hoboken) 2018;11:1-5. [PMID: 30992779 DOI: 10.1002/cld.681] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Ofei S, Gariepy C. When the Cause of Liver Disease Is the Heart. Journal of Pediatric Gastroenterology & Nutrition 2017;64:3-7. [DOI: 10.1097/mpg.0000000000001382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
3 Evans WN, Acherman RJ, Ciccolo ML, Carrillo SA, Galindo A, Rothman A, Winn BJ, Yumiaco NS, Restrepo H. MELD-XI Scores Correlate with Post-Fontan Hepatic Biopsy Fibrosis Scores. Pediatr Cardiol 2016;37:1274-7. [PMID: 27300556 DOI: 10.1007/s00246-016-1428-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
4 Lemmer A, VanWagner L, Gasanova Z, Helmke S, Everson GT, Ganger D. Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test. Congenit Heart Dis 2019;14:978-86. [PMID: 31369200 DOI: 10.1111/chd.12831] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Thrane KJ, Müller LSO, Suther KR, Thomassen KS, Holmström H, Thaulow E, Almaas R, Möller T, de Lange C. Spectrum of Fontan-associated liver disease assessed by MRI and US in young adolescents. Abdom Radiol (NY) 2021;46:3205-16. [PMID: 33688987 DOI: 10.1007/s00261-021-02994-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH, Book W, Gurvitz M, John A, John B, Marelli A, Marino BS, Minich LL, Poterucha JJ, Rand EB, Veldtman GR. Fontan-Associated Liver Disease. Journal of the American College of Cardiology 2017;70:3173-94. [DOI: 10.1016/j.jacc.2017.10.045] [Cited by in Crossref: 91] [Cited by in F6Publishing: 70] [Article Influence: 18.2] [Reference Citation Analysis]
7 Lui GK, Saidi A, Bhatt AB, Burchill LJ, Deen JF, Earing MG, Gewitz M, Ginns J, Kay JD, Kim YY, Kovacs AH, Krieger EV, Wu FM, Yoo S. Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation 2017;136. [DOI: 10.1161/cir.0000000000000535] [Cited by in Crossref: 66] [Cited by in F6Publishing: 34] [Article Influence: 13.2] [Reference Citation Analysis]
8 Geddes GC, Samudrala SS, Earing MG. Neonatal Assessment of Infants with Heterotaxy. Clin Perinatol 2020;47:171-82. [PMID: 32000924 DOI: 10.1016/j.clp.2019.10.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lemmer A, VanWagner LB, Ganger D. Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy. Hepatology. 2018;68:1633-1641. [PMID: 29672883 DOI: 10.1002/hep.30048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
10 Chavhan GB, Yoo SJ, Lam CZ, Khanna G. Abdominal Imaging of Children and Young Adults With Fontan Circulation: Pathophysiology and Surveillance. AJR Am J Roentgenol 2021;217:207-17. [PMID: 33909464 DOI: 10.2214/AJR.20.23404] [Reference Citation Analysis]
11 Ghaziani TT, Kwo PY. How clinicians may use tests of hepatic function now and in the future. Transl Res 2021;233:1-4. [PMID: 33826945 DOI: 10.1016/j.trsl.2021.03.014] [Reference Citation Analysis]
12 Chintakindi S, Boateng BA, Vodkin I, Herrick N, Moceri M, Raleigh D, Wang E, El-said H, Reeves R, Sepulveda JS, Alshawabkeh L. Alcohol use is prevalent among adults with the fontan circulation but does not correlate with liver disease. International Journal of Cardiology Congenital Heart Disease 2022. [DOI: 10.1016/j.ijcchd.2022.100339] [Reference Citation Analysis]
13 Munsterman ID, Duijnhouwer AL, Kendall TJ, Bronkhorst CM, Ronot M, van Wettere M, van Dijk APJ, Drenth JPH, Tjwa ETTL, van Dijk APJ, Drenth JPH, Duijnhouwer AL, van Kimmenade RRJ, van Koeverden SW, Munsterman ID, Tanke RB, Tjwa ETTL, Udink ten Cate FEA; Nijmegen Fontan Initiative. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort. European Heart Journal 2019;40:1057-68. [DOI: 10.1093/eurheartj/ehy620] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
14 Suda T, Sugimoto A, Kanefuji T, Abe A, Yokoo T, Hoshi T, Abe S, Morita S, Yagi K, Takahashi M, Terai S. Gravity assistance enables liver stiffness measurements to detect liver fibrosis under congestive circumstances. World J Hepatol 2022; 14(4): 778-790 [DOI: 10.4254/wjh.v14.i4.778] [Reference Citation Analysis]
15 Horvat N, Rocha MS, Chagas AL, Oliveira BC, Pacheco MP, Binotto MA, Ikari NM, Paranaguá-Vezozzo DC, Leao-Filho HM, Vicentini JRT, Moreira da Silva Filho MR, Jatene MB, Carrilho FJ, Cerri GG. Multimodality Screening of Hepatic Nodules in Patients With Congenital Heart Disease After Fontan Procedure: Role of Ultrasound, ARFI Elastography, CT, and MRI. AJR Am J Roentgenol 2018;211:1212-20. [PMID: 30247977 DOI: 10.2214/AJR.18.19762] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
16 Ofei SY, Texter K, Gariepy C, Smith S, Zaidi AN, Phelps C. Pediatric Fontan Associated Liver Disease: Non-invasive Evaluation with Serologic Markers and Acoustic Radiation Force Impulse (ARFI) Elastography. Prog Pediatr Cardiol 2019;53:21-7. [PMID: 32818014 DOI: 10.1016/j.ppedcard.2018.09.004] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Madala S, MacDougall K, Polavarapu A, Gurala D, Gumaste V, Morvillo G. An Emphasis on Screening to Detect Liver Cirrhosis and Hepatocellular Carcinoma in Patients Having Undergone the Fontan Procedure in Early Childhood. Case Rep Gastroenterol 2020;14:615-23. [PMID: 33362449 DOI: 10.1159/000510332] [Reference Citation Analysis]
18 Zafar F, Lubert AM, Trout AT, Katz DA, Palermo JJ, Opotowsky AR, Lorts A, Chin C, Powell AW, Villa CR, Anwar N, Morales DL, Dillman JR, Alsaied T. Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation. Radiology 2022;:211037. [PMID: 35289663 DOI: 10.1148/radiol.211037] [Reference Citation Analysis]
19 Alsaied T, Possner M, Lubert AM, Trout AT, Szugye C, Palermo JJ, Lorts A, Goldstein BH, Veldtman GR, Anwar N, Dillman JR. Relation of Magnetic Resonance Elastography to Fontan Failure and Portal Hypertension. Am J Cardiol 2019;124:1454-9. [PMID: 31474329 DOI: 10.1016/j.amjcard.2019.07.052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
20 Téllez L, Rodríguez de Santiago E, Albillos A. Fontan-Associated Liver Disease: Pathophysiology, Staging, and Management. Semin Liver Dis 2021. [PMID: 34399435 DOI: 10.1055/s-0041-1732355] [Reference Citation Analysis]
21 Budts W, Roos-Hesselink J, Rädle-Hurst T, Eicken A, McDonagh TA, Lambrinou E, Crespo-Leiro MG, Walker F, Frogoudaki AA. Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2016;37:1419-27. [PMID: 26787434 DOI: 10.1093/eurheartj/ehv741] [Cited by in Crossref: 109] [Cited by in F6Publishing: 81] [Article Influence: 18.2] [Reference Citation Analysis]
22 Granegger M, Thamsen B, Hubmann EJ, Choi Y, Beck D, Valsangiacomo Buechel E, Voutat M, Schweiger M, Meboldt M, Hübler M. A long-term mechanical cavopulmonary support device for patients with Fontan circulation. Medical Engineering & Physics 2019;70:9-18. [DOI: 10.1016/j.medengphy.2019.06.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
23 Kay WA, Moe T, Suter B, Tennancour A, Chan A, Krasuski RA, Zaidi AN. Long Term Consequences of the Fontan Procedure and How to Manage Them. Prog Cardiovasc Dis 2018;61:365-76. [PMID: 30236751 DOI: 10.1016/j.pcad.2018.09.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
24 Nandwana SB, Olaiya B, Cox K, Sahu A, Mittal P. Abdominal Imaging Surveillance in Adult Patients After Fontan Procedure: Risk of Chronic Liver Disease and Hepatocellular Carcinoma. Current Problems in Diagnostic Radiology 2018;47:19-22. [DOI: 10.1067/j.cpradiol.2017.04.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
25 Sakamoto T, Nagashima M, Hiramatsu T, Matsumura G, Park I, Yamazaki K. Fontan circulation over 30 years. What should we learn from those patients? Asian Cardiovasc Thorac Ann 2016;24:765-71. [DOI: 10.1177/0218492316667771] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
26 Surrey LF, Russo P, Rychik J, Goldberg DJ, Dodds K, O'Byrne ML, Glatz AC, Rand EB, Lin HC. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation. Hum Pathol 2016;57:106-15. [PMID: 27476041 DOI: 10.1016/j.humpath.2016.07.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]